European Heart Journal Advance Access published online on August 25, 2005
European Heart Journal, doi:10.1093/eurheartj/ehi465
| ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
1 J. Uriach y Compañía, S.A., Polígon Industrial Riera de Caldes, Avinguda Camí Reial, 51-57, Palau-solità i Plegamans, 08184 Barcelona, Spain
* To whom correspondence should be addressed.
Letter to the Editor
Ezetimibe coadministered with fenofibrate: some safety questions
Javier Borja, E-mail: fv-borja{at}uriach.com
![]()
CiteULike
Connotea
Del.icio.us What's this?
This article has been cited by other articles:
![]() |
C. D Meyers, Y. S. Moon, H. Ghanem, and N. D Wong Type Of Preexisting Lipid Therapy Predicts LDL-C Response to Ezetimibe Ann. Pharmacother., May 1, 2006; 40(5): 818 - 823. [Abstract] [Full Text] [PDF] |
||||
